Cerene Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
Series C
- (In Progress)
- Latest Deal Amount
-
$30M
- Investors
-
10
Cerene General Information
Description
Developer of a medical device designed to treat heavy menstrual bleeding by reducing the uterine lining. The company offers an endometrial cryotherapy device using controlled cooling technology that can be administered in a physician's office without incisions or general anesthesia, enabling gynecologists to provide a minimally invasive treatment option for premenopausal women with heavy menstrual bleeding caused by benign conditions.
Contact Information
Website
www.cerene.comCorporate Office
- 2919 Seventh Street
- Berkeley, CA 94710
- United States
Corporate Office
- 2919 Seventh Street
- Berkeley, CA 94710
- United States
Cerene Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series C) | 20-Aug-2026 | $30M | In Progress | Generating Revenue | ||
| 8. Later Stage VC (Series B1) | 29-Mar-2024 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B) | 09-Sep-2021 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 24-Sep-2020 | Completed | Clinical Trials - General | |||
| 5. Merger/Acquisition | 01-Jan-2018 | Cancelled | Clinical Trials - General | |||
| 4. Later Stage VC (Series C1) | 23-Aug-2017 | Completed | Clinical Trials - General | |||
| 3. Later Stage VC (Series C) | 20-Jul-2015 | Completed | Clinical Trials - General | |||
| 2. Early Stage VC (Series B) | 02-May-2013 | $9.8M | $10.8M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 24-Feb-2012 | $1M | $1M | Completed | Startup |
Cerene Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-1 | ||||||||
| Series B | ||||||||
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | 3,613,327 | $0.000100 | 8% | $0.17 | $0.17 | $0.17 | 0.89% | |
| Series A-1 | 5,276,319 | $0.000100 | 8% | $0.05 | $0.05 | $0.05 | 1.31% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cerene Comparisons
Industry
Financing
Details
Cerene Competitors (19)
One of Cerene’s 19 competitors is Vygon (uk) Ltd., a Corporation company based in Hilton Head Island, SC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vygon (uk) Ltd. | Corporation | Hilton Head Island, SC | ||||
| HistoSonics | Private Equity-Backed | Plymouth, MN | ||||
| Verathon | Formerly PE-Backed | Bothell, WA | ||||
| Alpha Omega Engineering | Formerly VC-backed | Nazareth, Israel | ||||
| Ad-Tech Medical Instrument | Formerly PE-Backed | Oak Creek, WI |
Cerene Patents
Cerene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021426845-A1 | Cryogenic treatment device encoder | Active | 09-Feb-2021 | ||
| AU-2021426845-A9 | Cryogenic treatment device encoder | Active | 09-Feb-2021 | ||
| AU-2021426845-B2 | Cryogenic treatment device encoder | Active | 09-Feb-2021 | ||
| CA-3200231-A1 | Cryogenic treatment device encoder | Pending | 09-Feb-2021 | ||
| EP-4247283-A1 | Cryogenic treatment device encoder | Active | 09-Feb-2021 | A61B18/00 |
Cerene Signals
Cerene Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Charles & Potomac Capital | Family Office | Minority | ||
| Dais Partners | Growth/Expansion | Minority | ||
| Tullis Health Investors | Growth/Expansion | Minority | ||
| InnovaHealth Partners | Growth/Expansion | Minority | ||
| AG Hill Partners | Family Office | Minority |
Cerene FAQs
-
When was Cerene founded?
Cerene was founded in 2009.
-
Where is Cerene headquartered?
Cerene is headquartered in Berkeley, CA.
-
What is the size of Cerene?
Cerene has 50 total employees.
-
What industry is Cerene in?
Cerene’s primary industry is Other Devices and Supplies.
-
Is Cerene a private or public company?
Cerene is a Private company.
-
What is Cerene’s current revenue?
The current revenue for Cerene is .
-
How much funding has Cerene raised over time?
Cerene has raised $89.8M.
-
Who are Cerene’s investors?
Charles & Potomac Capital, Dais Partners, Tullis Health Investors, InnovaHealth Partners, and AG Hill Partners are 5 of 10 investors who have invested in Cerene.
-
Who are Cerene’s competitors?
Vygon (uk) Ltd., HistoSonics, Verathon, Alpha Omega Engineering, and Ad-Tech Medical Instrument are some of the 19 competitors of Cerene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process